Get the App
A

Aldeyra Therapeutics (ALDX)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Aldeyra Therapeutics (ALDX)

Aldeyra Therapeutics, Inc. is a biotechnology company, which is engaged in developing immune-modulating therapies to treat ocular and systemic diseases. The Company's lead product candidate, reproxalap, is a treatment in late-stage development for dr... Read more

  • USD9.00
  • USD9.13
  • USD8.41
  • USD9.20
  • 26.10%
  • --
  • 1.53M
  • 668.29k
  • 529M
  • 2.36
  • 87.30%

Stock News

The Moneyist: ‘They do not trust her, nor do I’: My elderly parents fear my sister will empty their bank accounts and steal their possessions. What can we do?

56 minutes ago

The Moneyist: ‘They do not trust her, nor do I’: My elderly parents fear my sister will empty their bank accounts and steal their possessions. What can we do?

MarketWatch

Cohen & Steers Closed-End Funds Declare Distributions for April, May, and June 2023

1 hour ago

Cohen & Steers Closed-End Funds Declare Distributions for April, May, and June 2023

Yahoo

Living With Climate Change: Wind damage will impact more U.S. homes than before, in Florida especially. How best to protect your property.

1 hour ago

Living With Climate Change: Wind damage will impact more U.S. homes than before, in Florida especially. How best to protect your property.

MarketWatch

PowerSchool Introduces International Localization Framework to Support Growing Global Customer Base

1 hour ago

PowerSchool Introduces International Localization Framework to Support Growing Global Customer Base

Yahoo

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.

Try Premium